ArticleClinical proteomics2018

Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases.

Nina Zila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.